In March 2025, the company declared new programs for any immediate-to-client providing of its Wegovy weight loss drug. The company set up a fresh pharmacy, termed NovoCare, which might cost buyers $499 each month for entry to the drug, under fifty percent the expense of the drug by other pharmac